Picture of Repligen logo

RGEN — Repligen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Repligen Corp reports results for the quarter ended in September - Earnings Summary

* Repligen Corp  RGEN.OQ  reported quarterly adjusted
earnings of
77 cents​​ per share for the quarter ended in September. The
mean expectation of nine analysts for the quarter was
for earnings of 68 cents per share.
    * Revenue rose 12.6% to $200.74 million from a year ago;
analysts
expected $191.50 million. 
    * Repligen Corp's reported EPS for the quarter was 71
cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.9%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Repligen Corp shares had fallen by 2.5% this quarter and
lost 31.1% so far this year.
    * The company reported quarterly net income of $40.41
million.
    * Wall Street's median 12-month price target for Repligen
Corp is
$260.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
1 at 01:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      0.68           0.77           Beat
 Jun. 30 2022      0.72           0.91           Beat
 Mar. 31 2022      0.72           0.92           Beat
 Dec. 31 2021      0.65           0.81           Beat

Recent news on Repligen

See all news